403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Medicenna Therapeutics Corp.
(MENAFN- Baystreet) 11:15 AM EST - Medicenna Therapeutics Corp.: Was featured in a poster presentation describing the investigator-sponsored NEO-CYT trial at the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago last week. Medicenna Therapeutics Corp.
shares T are trading up $0.01 at $0.43.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
Comments
No comment